The revenue grew by 3 per cent Y-o-Y to Rs 2,809 crore as markets like Brazil and the US experienced decline
Total revenues on a consolidated basis in Q3FY25 stood at Rs 41,378 crore, down 1.3 per cent Y-o-Y from Rs 41,940 crore a year ago
BPCL's reported gross refining margins (GRMs) stood at $5.6 per barrel or bbl ($4.4/bbl in Q2FY25). Refining throughput was 9.5 metric million tonnes or mmt (-3 per cent Y-o-Y)
Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement
The impairment provision for financial instruments rose to Rs 751.9 crore in Q3FY25, up from Rs 126.2 crore in Q3FY24
Sequentially, the Mumbai-based lender's net profit rose by 6 per cent from Rs 2,374 crore in June 2024 (Q2FY25). Its stock closed 1.5 per cent lower at Rs 98.3 per share on BSE
The company recorded pre-sales of Rs 220 crore during Q3 FY25
By December 31 last year, the company's total assets under management increased by 19 per cent to Rs 2,54,469.69 crore
Mindspace Business Parks REIT Q3FY25 results: Company declared a distribution of Rs 315 crore for the October-December quarter
The drug maker had reported a profit after tax (PAT) of Rs 443 crore in the October-December quarter of the last fiscal
Godrej Consumer Products Q3FY25 results: The company declared an interim dividend of Rs 5 per share for FY25
Interglobe Aviation Q3FY25 results: Indigo carried 27.325 million passengers, commanding a market share of 63.8%, compared to 24.31 million passengers and a 62.1% share a year ago
Prestige & Above segment accounted for 89.2% of net sales during the quarter, up 1.0 ppts over the prior year. Prestige & above segment net sales increased 16.1% in Q3 FY25
Drug firm Granules India on Friday said its consolidated profit after tax declined 6 per cent year on year to Rs 118 crore for the third quarter ended December 31, 2024. The company reported a profit after tax of Rs 126 crore in the October-December quarter of the last fiscal. Revenue from operations declined to Rs 1,138 crore in the third quarter as against Rs 1,156 crore in the year-ago period, the Hyderabad-based said in a regulatory filing. "We continue to sustain our profitable growth in the finished dosages segment, driven by our North America business. We are enhancing quality and compliance through systemic improvements across our operations, including Gagillapur," Granules India Chairman & Managing Director Krishna Prasad Chigurupati said. The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations. Subsequently, the production resumed in October in a staggered manner, it ...
The revenue of the company for the quarter under review stood at Rs 868 crore as compared to Rs 782 crore a year ago which implies a rise of 11 per cent year-on-year (Y-o-Y)
V2 Retail released its Q3 results on Thursday, after market hours, which showed that the company's consolidated net profit rose 118 per cent to Rs 685 crore as compared to Rs 314 crore a year ago
KFin Technologies released its Q3 results on Thursday, after market hours, which showed that the company's consolidated net profit rose 35 per cent to Rs 90 crore as compared to Rs 67 crore a year ago
Suryoday Small Finance Bank share slipped 7.44 per cent at Rs125 a piece on the BSE in Friday's intraday trade
During the quarter, Discovery Services launched "China+1" pilots with large and mid-size pharma companies and converted them into long-term contracts. Growth signals stabilizing
Ujjivan Small Finance Bank share slipped 6.48 per cent at Rs 32.32 a piece on the BSE in Friday's intraday trade